| Steele, Ralph |
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia |
|
|
| Completed | 3 | 214 | US | Pitolisant Oral Tablet, Placebo oral tablet | Harmony Biosciences, LLC | Idiopathic Hypersomnia | 08/23 | 08/23 | | |
| Shipp, Anna |
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 3 | 576 | Canada, US | Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer | United Therapeutics | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 06/25 | 06/25 | | |
|
|
TETON-PPF, NCT05943535: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis |
|
|
| Recruiting | 3 | 698 | Canada, US | Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer | United Therapeutics | Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 11/27 | 11/27 | | |
NCT05671835: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 2 | 100 | US | TTI-101, Placebo | Tvardi Therapeutics, Incorporated | Idiopathic Pulmonary Fibrosis | 03/25 | 03/25 | | |
| MacKinnon, Susan |
NCT05671835: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 2 | 100 | US | TTI-101, Placebo | Tvardi Therapeutics, Incorporated | Idiopathic Pulmonary Fibrosis | 03/25 | 03/25 | | |
| Grullon, Kevin |
RheSolve, NCT04677465: Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis |
|
|
| Active, not recruiting | N/A | 270 | Europe, US | RheOx Bronchial Rheoplasty, Sham Procedure | Gala Therapeutics, Inc. | Chronic Bronchitis | 05/24 | 10/25 | | |
| Wood, Erik |
ACTRN12619000555156p: Ketamine versus nitrous oxide plus intranasal fentanyl for paediatric fracture reduction in the emergency department: a prospective randomised comparison trial |
|
|
| Not yet recruiting | 3 | 216 | | | David Bishop, Redcliffe Hospital, in kind support | Paediatric fractures requiring manipulation / reduction
| | | | |
ACTRN12619000555156: Ketamine versus nitrous oxide plus intranasal fentanyl for paediatric fracture reduction in the emergency department: a prospective randomised comparison trial |
|
|
| Not yet recruiting | 3 | 216 | | | David Bishop, Redcliffe Hospital, in kind support | Paediatric fractures requiring manipulation / reduction
| | | | |
| Recruiting | 1 | 30 | | | Dr Erik Wood, Redcliffe Hospital Private Practice Trust Fund, Emergency Medicine Foundation | Refractory Headache | | | | |
| Lliran, Gabriela |
NCT05156047: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia |
|
|
| Completed | 3 | 214 | US | Pitolisant Oral Tablet, Placebo oral tablet | Harmony Biosciences, LLC | Idiopathic Hypersomnia | 08/23 | 08/23 | | |
| Cirillo, Julia |
NCT04482595: BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients |
|
|
| Recruiting | 2 | 50 | US | BIO 300 Oral Suspension, Placebo | Humanetics Corporation, NYU Langone Health, National Institute of Allergy and Infectious Diseases (NIAID) | COVID-19, Long COVID, Pulmonary Fibrosis, Post-acute Respiratory Complications of COVID-19 | 06/24 | 04/25 | | |
NCT05671835: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis |
|
|
| Recruiting | 2 | 100 | US | TTI-101, Placebo | Tvardi Therapeutics, Incorporated | Idiopathic Pulmonary Fibrosis | 03/25 | 03/25 | | |
